Bionano Genomics, Inc. (NASDAQ: BNGO) had its price target lowered by analysts at BTIG Research from $3.00 to $2.00. They now have a "buy" rating on the stock.
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis [Yahoo! Finance]
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]